Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Subscriber?

Search Results for: Theranos CLIA

Elizabeth Holmes of Theranos Speaks at AACC To Skeptical PhDs, Pathologists, and Press

Clinical Laboratory / By

CEO SUMMARY: Elizabeth Holmes, Founder and CEO of Theranos, Inc., was given the ideal platform by AACC to show the science behind her lab company’s much-touted diagnostic technologies. But in a surprise to the assembled audience, Holmes, accompanied by three PhDs on her team, chose to discuss: a) her company’s new business strategy; b) an …

Elizabeth Holmes of Theranos Speaks at AACC To Skeptical PhDs, Pathologists, and Press Read More »

To access this post, you must purchase The Dark Report.

Theranos Now Scrambling To Save What It Can

Clinical Laboratory / By

CEO SUMMARY: On July 7, CMS imposed severe sanctions on Theranos for CLIA violations. Included is a two-year ban on owning and operating a clinical laboratory for Theranos, CEO Elizabeth Holmes, the former COO, and the former medical director. Theranos appears to be pivoting away from a clinical lab testing business strategy and back to …

Theranos Now Scrambling To Save What It Can Read More »

To access this post, you must purchase The Dark Report.

Of Theranos, ADLTs, and Surgical Pathology Errors

Commentary and Opinion by R. Lewis Dark / By

THESE DAYS, IT SURE FEELS LIKE CLINICAL LABS AND PATHOLOGY GROUPS are under constant siege. Every month seems to bring one or more new developments that rock the clinical lab industry. Theranos, Inc. is a prime example of this phenomenon. Almost every month there are new disclosures about problems plaguing this high-profile lab company. As …

Of Theranos, ADLTs, and Surgical Pathology Errors Read More »

To access this post, you must purchase The Dark Report.

Walgreens Tells Theranos: ‘Lab Deal Is Terminated’

Laboratory Compliance / By

BREAKING NEWS: As this issue of THE DARK REPORT went to press, it was learned that Walgreens had announced the termination of its lab testing agreement with Theranos, effective immediately. Theranos loses access to about 40 Walgreens pharmacies in Phoenix and is left with about five patient collection centers. The following story summarizes developments involving …

Walgreens Tells Theranos: ‘Lab Deal Is Terminated’ Read More »

To access this post, you must purchase The Dark Report.

Up to 30,000 Theranos test results voided; Walgreen dumps partnership

TDR Insider / By

This is an excerpt from a 1,000-word article in the June 13 issue of THE DARK REPORT. The original article is available to paid members of the Dark Intelligence Group.   EXECUTIVE SUMMARY: The disruptor’s plans have been thoroughly disrupted. As this issue of  THE DARK REPORT went to press, it was learned that Walgreens had announced …

Up to 30,000 Theranos test results voided; Walgreen dumps partnership Read More »

To access this post, you must purchase The Dark Report.

AACC reveals details of its invitation to Theranos CEO

TDR Insider / By

This is an excerpt from a 925-word article in the May 23 issue of THE DARK REPORT. The complete article is available to paid members of the Dark Intelligence Group.  CEO SUMMARY: In its latest lab industry scoop, THE DARK REPORT has reached out to American Association of Clinical Chemistry (AACC) leaders to find out how …

AACC reveals details of its invitation to Theranos CEO Read More »

To access this post, you must purchase The Dark Report.

Theranos Saga Just Keeps Getting More Intriguing

TDR Insider / By

IT’S BEEN AN EVENTFUL COUPLE OF MONTHS for Theranos, the lab testing company that says its goal is to disrupt the clinical laboratory industry. Novelists cannot write fiction as compelling as the unfolding real story about this controversial company.

During March and April, The Wall Street Journal published a series of articles that revealed the extent of the problems Theranos had with CLIA inspections of its clinical laboratory in Newark, California. The Journal published its analysis of the CLIA inspection report and the serious deficiencies identified during lab inspections that happened last fall and earlier this year.

To access this post, you must purchase The Dark Report.

Theranos in the News, for Better and Worse

Commentary and Opinion by R. Lewis Dark / By

IT’S BEEN AN EVENTFUL COUPLE OF MONTHS for Theranos, the lab testing company that says its goal is to disrupt the clinical laboratory industry. Novelists cannot write fiction as compelling as the unfolding real story about this controversial company.

During March and April, The Wall Street Journal published a series of articles that revealed the extent of the problems Theranos had with CLIA inspections of its clinical laboratory in Newark, California. The Journal published its analysis of the CLIA inspection report and the serious deficiencies identified during lab inspections that happened last fall and earlier this year.

To access this post, you must purchase The Dark Report.

Washington Post: Theranos Approached Military in 2012

Clinical Laboratory / By

SINCE THE WALL STREET JOURNAL published its exposé of Theranos Inc. in October, other media outlets have published the findings of their own investigations into various aspects of the lab company’s practices. One example is the disclosure by The Wall Street Journal in November that Theranos had an agreement with Safeway to put blood collection …

Washington Post: Theranos Approached Military in 2012 Read More »

To access this post, you must purchase The Dark Report.

Facebook-f Twitter Linkedin-in

The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: customerservice@darkintelligencegroup.com

© 2022 The Dark Report. All rights reserved.

;